Your browser doesn't support javascript.
loading
Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids.
Ibrahim, Fowzia; Choy, Ernest; Gordon, Patrick; Doré, Caroline J; Hakim, Alan; Kitas, George; Isenberg, David; Griffiths, Bridget; Lecky, Bryan; Chakravarty, Kuntal; Winer, John; Danko, Katalin; Cooper, Robert G; White-Alao, Beverley; Scott, David L.
Afiliação
  • Ibrahim F; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • Choy E; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • Gordon P; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • Doré CJ; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • Hakim A; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • Kitas G; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • Isenberg D; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • Griffiths B; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • Lecky B; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • Chakravarty K; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • Winer J; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • Danko K; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • Cooper RG; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • White-Alao B; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
  • Scott DL; Department of Rheumatology, King's College London, London, Cardiff Institute of Infection & Immunity, Cardiff University School of Medicine, Cardiff, MRC Clinical Trials Unit, Department of Rheumatology, Whipps Cross University Hospital, London, Rheumatology, Russells Hall Hospital, Dudley Group
Rheumatology (Oxford) ; 54(6): 1050-5, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25433040
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metotrexato / Ciclosporina / Corticosteroides / Imunossupressores / Miosite Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Male Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metotrexato / Ciclosporina / Corticosteroides / Imunossupressores / Miosite Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Male Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2015 Tipo de documento: Article